Michael D. Caldwell

Ross S. Kleiman, Paul S. Bennett, Peggy L. Peissig et al.

The widespread digitization of patient data via electronic health records (EHRs) has created an unprecedented opportunity to use machine learning algorithms to better predict disease risk at the patient level. Although predictive models have previously been constructed for a few important diseases, such as breast cancer and myocardial infarction, we currently know very little about how accurately the risk for most diseases or events can be predicted, and how far in advance. Machine learning algorithms use training data rather than preprogrammed rules to make predictions and are well suited for the complex task of disease prediction. Although there are thousands of conditions and illnesses patients can encounter, no prior research simultaneously predicts risks for thousands of diagnosis codes and thereby establishes a comprehensive patient risk profile. Here we show that such pandiagnostic prediction is possible with a high level of performance across diagnosis codes. For the tasks of predicting diagnosis risks both 1 and 6 months in advance, we achieve average areas under the receiver operating characteristic curve (AUCs) of 0.803 and 0.758, respectively, across thousands of prediction tasks. Finally, our research contributes a new clinical prediction dataset in which researchers can explore how well a diagnosis can be predicted and what health factors are most useful for prediction. For the first time, we can get a much more complete picture of how well risks for thousands of different diagnosis codes can be predicted.

Zhaobin Kuang, James Thomson, Michael Caldwell et al.

Computational Drug Repositioning (CDR) is the task of discovering potential new indications for existing drugs by mining large-scale heterogeneous drug-related data sources. Leveraging the patient-level temporal ordering information between numeric physiological measurements and various drug prescriptions provided in Electronic Health Records (EHRs), we propose a Continuous Self-controlled Case Series (CSCCS) model for CDR. As an initial evaluation, we look for drugs that can control Fasting Blood Glucose (FBG) level in our experiments. Applying CSCCS to the Marshfield Clinic EHR, well-known drugs that are indicated for controlling blood glucose level are rediscovered. Furthermore, some drugs with recent literature support for the potential effect of blood glucose level control are also identified.

Jesse Davis, Vitor Santos Costa, Peggy Peissig et al.

Learning from electronic medical records (EMR) is challenging due to their relational nature and the uncertain dependence between a patient's past and future health status. Statistical relational learning is a natural fit for analyzing EMRs but is less adept at handling their inherent latent structure, such as connections between related medications or diseases. One way to capture the latent structure is via a relational clustering of objects. We propose a novel approach that, instead of pre-clustering the objects, performs a demand-driven clustering during learning. We evaluate our algorithm on three real-world tasks where the goal is to use EMRs to predict whether a patient will have an adverse reaction to a medication. We find that our approach is more accurate than performing no clustering, pre-clustering, and using expert-constructed medical heterarchies.